NP / PA
Mission Grove Medical Corporation
Mission Grove Medical Corporation was paid $1.65M by Medicaid between Jan 2018 and Nov 2024, across 31 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 37% of everything it billed.
33Billing provider infoMISSION GROVE MEDICAL CORPORATION
RIVERSIDE, CA 92508
RIVERSIDE, CA 92508
33aNPI1205224417assigned 12/23/2014
33bProvider typeNurse Practitioner
28Total paid$1.65M
24GClaims45,075
24DCodes billed31
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Nurse Practitioner providers in California
Rank by total paid#6 of 84
Median peer was paid$4K
This provider vs. median417×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 6,019 | $328K | |
| 2019 | 8,158 | $307K | |
| 2020 | 5,300 | $181K | |
| 2021 | 5,617 | $205K | |
| 2022 | 7,055 | $247K | |
| 2023 | 6,422 | $208K | |
| 2024incomplete | 6,504 | $175K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 37% | 17,023 | 15,384 | $616K |
| S9083 | Global fee urgent care centers | 24% | 7,243 | 6,457 | $398K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 17% | 4,057 | 4,051 | $278K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 12% | 3,343 | 3,335 | $190K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 4.1% | 2,790 | 2,621 | $67K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 3.0% | 2,563 | 2,474 | $50K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 1.6% | 482 | 465 | $27K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 327 | 325 | $9K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 133 | 132 | $4K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,821 | 1,780 | $3K |
| 81003 | <1% | 1,809 | 1,738 | $3K | |
| 99000 | <1% | 1,008 | 984 | $2K |
19 more codes
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 245 | $1K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 239 | $1K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 174 | $946.98 |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 22 | $790.38 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 118 | $204.48 |
| 94760 | <1% | 29 | $149.31 | |
| 94664 | <1% | 12 | $78.15 | |
| 99441 | <1% | 130 | $26.10 | |
| 99442 | <1% | 40 | $20.89 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 14 | $3.88 |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 12 | $1.44 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 96 | $0.16 |
| H0001 | Alcohol and/or drug assessment | 0% | 500 | $0.00 |
| G9459 | Currently a tobacco non-user | 0% | 330 | $0.00 |
| H0049 | Alcohol and/or drug screening | 0% | 65 | $0.00 |
| 2010F | 0% | 34 | $0.00 | |
| 99443 | 0% | 42 | $0.00 | |
| 1033F | 0% | 288 | $0.00 | |
| 99401 | 0% | 86 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLACOMBE, JEAN (AO)